Falcon Pharmaceuticals, Ltd., an affiliate of Alcon Laboratories Inc., is the largest manufacturer and marketer of generic ophthalmic and otic products in the U.S. Falcon distributes a wide range of generic ophthalmic and otic products designed to treat a variety of diseases related to the eye and ear. Utilizing the technical expertise and experience offered by Alcon allows Falcon to deliver a quality and economical product to the marketplace. Alcon’s dedication to ophthalmology for more than 50 years helps separate Falcon from the competition.
With the climate of today’s healthcare industry and the advancement of managed care it is important to bring economically priced products to market. Technology and the expertise of Alcon’s product development staff allows Falcon to introduce new generic products in many instances before our competition, thus offering cost savings much sooner to the consumer.
Falcon offers a variety of exclusive generic products including Timolol GFS 0.25% and 0.5% (compares to Aton Pharma, Inc.’s TIMOPTIC-XE® 0.25% & 0.5%), Trifluridine Ophthalmic Solution, 1% (compares to Monarch’s VIROPTIC®) and the combination drug Neomycin and Polymyxin B Sulfates and Hydrocortisone Ophthalmic Suspension (compares to Monarch’s CORTISPORIN® Ophthalmic Suspension). Currently Falcon offers 30 families of multi-source generic products with plans to add many new generic ophthalmic and otic products as brand product patents expire.
Falcon Pharmaceuticals, Ltd. is poised to meet the needs of the customer now and in the future. With the support of Alcon, a global leader in research and development, Falcon is and will continue to be a key component in today’s healthcare industry.